State of Wisconsin Investment Board Portfolio holdings
AUM
$40.9B
1-Year Return
24.31%
This Quarter Return
+12.66%
1 Year Return
+24.31%
3 Year Return
+99.94%
5 Year Return
+177.86%
10 Year Return
+427.44%
AUM
$35.3B
AUM Growth
+$3.32B
(+10%)
Cap. Flow
-$212M
Cap. Flow
% of AUM
-0.6%
Top 10 Holdings %
Top 10 Hldgs %
21.66%
Holding
2,642
New
138
Increased
1,044
Reduced
1,118
Closed
290
Top Buys
| 1 |
Invesco Senior Loan ETF
BKLN
|
+$150M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$129M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$126M |
| 4 |
NVIDIA
NVDA
|
+$76.7M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$69.8M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$96M |
| 2 |
Petrobras Class A
PBR.A
|
+$92.7M |
| 3 |
Toronto Dominion Bank
TD
|
+$59.7M |
| 4 |
Royal Bank of Canada
RY
|
+$58.6M |
| 5 |
Canadian Natural Resources
CNQ
|
+$49.8M |
Sector Composition
| 1 | Technology | 25.13% |
| 2 | Financials | 11.76% |
| 3 | Healthcare | 11.62% |
| 4 | Consumer Discretionary | 10.43% |
| 5 | Industrials | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Arvinas
ARVN
$557M
| $2.1M | 0.01% |
51,096
+6,983
| +16% | +$287K |
|
1227
Mohawk Industries
MHK
$8.52B
| $2.06M | 0.01% |
19,917
-50,388
| -72% | -$5.22M |
|
1228
Crinetics Pharmaceuticals
CRNX
$3.16B
| $2.06M | 0.01% |
57,768
+7,496
| +15% | +$267K |
|
1229
Madrigal Pharmaceuticals
MDGL
$9.62B
| $2.05M | 0.01% |
8,857
-2,276
| -20% | -$527K |
|
1230
Transmedics
TMDX
$3.86B
| $2.03M | 0.01% |
25,694
+21,968
| +590% | +$1.73M |
|
1231
Intellia Therapeutics
NTLA
$1.23B
| $2.01M | 0.01% |
65,929
-810
| -1% | -$24.7K |
|
1232
Axsome Therapeutics
AXSM
$5.88B
| $2.01M | 0.01% |
25,218
-3,939
| -14% | -$314K |
|
1233
Lucid Motors
LCID
$5.93B
| $1.98M | 0.01% |
47,118
-1,270
| -3% | -$53.5K |
|
|
MRTX
1234
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.97M | 0.01% |
33,503
-1,601
| -5% | -$94.1K |
|
1235
WIX.com
WIX
$9.42B
| $1.97M | 0.01% |
15,978
-1,400
| -8% | -$172K |
|
1236
Denali Therapeutics
DNLI
$2.12B
| $1.96M | 0.01% |
91,521
-6,335
| -6% | -$136K |
|
1237
Veracyte
VCYT
$2.46B
| $1.94M | 0.01% |
70,515
+9,933
| +16% | +$273K |
|
1238
OGE Energy
OGE
$8.97B
| $1.94M | 0.01% |
55,433
-43,855
| -44% | -$1.53M |
|
1239
Pacific Biosciences
PACB
$360M
| $1.92M | 0.01% |
196,021
+28,245
| +17% | +$277K |
|
1240
Nuvalent
NUVL
$5.81B
| $1.92M | 0.01% |
26,066
-5,574
| -18% | -$410K |
|
1241
Concentrix
CNXC
$3.4B
| $1.9M | 0.01% |
19,313
-15,667
| -45% | -$1.54M |
|
1242
IDEAYA Biosciences
IDYA
$2.18B
| $1.88M | 0.01% |
52,976
-11,134
| -17% | -$396K |
|
1243
Schrodinger
SDGR
$1.37B
| $1.88M | 0.01% |
52,583
+12,349
| +31% | +$442K |
|
1244
Radian Group
RDN
$4.78B
| $1.88M | 0.01% |
65,786
-7,919
| -11% | -$226K |
|
1245
Collegium Pharmaceutical
COLL
$1.19B
| $1.87M | 0.01% |
60,668
+33,277
| +121% | +$1.02M |
|
1246
Krystal Biotech
KRYS
$4.11B
| $1.85M | 0.01% |
14,896
-5,731
| -28% | -$711K |
|
1247
Aehr Test Systems
AEHR
$792M
| $1.84M | 0.01% |
+69,507
| New | +$1.84M |
|
1248
Innoviva
INVA
$1.21B
| $1.84M | 0.01% |
114,566
+31,349
| +38% | +$503K |
|
1249
CryoPort
CYRX
$437M
| $1.83M | 0.01% |
118,435
+77,036
| +186% | +$1.19M |
|
1250
Fluence Energy
FLNC
$905M
| $1.83M | 0.01% |
+76,836
| New | +$1.83M |
|